FFA
RVMD icon

Farther Finance Advisors’s Revolution Medicines RVMD Stock Holding History

Farther Finance Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$995K Buy
4,848
+2,751
+131% +$545K 0.01% 1139
2026
Q2 		$394K Buy
2,097
+1,129
+117% +$165K ﹤0.01% 1738
2026
Q1 		$95.5K Buy
968
+217
+29% +$21.9K ﹤0.01% 2545
2025
Q4 		$59.8K Buy
751
+232
+45% +$15.2K ﹤0.01% 2693
2025
Q3 		$24.2K Buy
519
+7
+1% +$274 ﹤0.01% 2907
2025
Q2 		$18.8K Buy
512
+82
+19% +$3.15K ﹤0.01% 2713
2025
Q1 		$14.5K Sell
430
-1,621
-79% -$65.8K ﹤0.01% 2553
2024
Q4 		$89.7K Buy
2,051
+1,613
+368% +$81.4K ﹤0.01% 1354
2024
Q3 		$19.9K Buy
438
+30
+7% +$1.31K ﹤0.01% 2080
2024
Q2 		$15.8K Buy
408
+57
+16% +$2.13K ﹤0.01% 1871
2024
Q1 		$11.1K Sell
351
-11
-3% -$326 ﹤0.01% 1717
2023
Q4 		$10.4K Buy
+362
New +$8.7K ﹤0.01% 1588

Other funds holding RVMD

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CGFA
Colton Groome Financial Advisors Asheville, North Carolina $427M AUM 13.21% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Farther Finance Advisors's RVMD Position: Q3 2026 in Review

Farther Finance Advisors increased its Revolution Medicines (RVMD) stake by 131% in Q3 2026, buying an estimated $545K and bringing the position to 4,848 shares worth $995K. The position accounts for 0.01% of the portfolio, ranked #1139.

Farther Finance Advisors first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. 17 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Farther Finance Advisors held 4,848 shares of Revolution Medicines worth $995K as of Q3 2026.
  • Farther Finance Advisors bought 2,751 Revolution Medicines shares in Q3 2026, an estimated $545K.
  • Revolution Medicines made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1139 holding.
  • Farther Finance Advisors first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
  • 17 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.